Companies: 48,874 Total Market Cap: 132104787226985.81

Stevanato Group S.p.A.

NYSE: STVN
Healthcare Medical Instruments & Supplies
Rank #2623
Market Cap 6.49 B
Volume 19,628
Price 23.78
Change (%) 1.00%
Country or region Italy Italy

Stevanato Group S.p.A.'s latest marketcap:

6.49 B

As of 05/19/2025, Stevanato Group S.p.A.'s market capitalization has reached $6.49 B. According to our data, Stevanato Group S.p.A. is the 2623th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 6.49 B
Revenue (ttm) 1.22 B
Net Income (ttm) 135.63 M
Shares Out 272.90 M
EPS (ttm) 0.50
Forward PE 38.60
Ex-Dividend Date 06/04/2024
Earnings Date 05/08/2025
Market Cap Chart
Data Updated: 05/19/2025

Stevanato Group S.p.A.'s yearly market capitalization.

Stevanato Group S.p.A. has seen its market value grow from $5.94 B to $6.49 B since 2021, representing a total increase of 9.21% and an annual compound growth rate (CAGR) of 2.64%.
Date Market Cap Change (%)
05/19/2025 $6.49 B 0.05%
12/31/2024 $5.95 B -18.16%
12/29/2023 $7.27 B 52.74%
12/30/2022 $4.76 B -19.96%
12/31/2021 $5.94 B

Company Profile

About Stevanato Group S.p.A.

Stevanato Group S.p.A. is a global leader in providing innovative solutions for the biopharma and healthcare industries. Headquartered in Piombino Dese, Italy, the company operates across Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Business Segments

  • Biopharmaceutical and Diagnostic Solutions: Offers drug containment, in-vitro diagnostics, and drug delivery systems.
  • Engineering: Provides analytical services, medical devices, and manufacturing equipment.

Products and Services

  • Drug Containment: Pre-fillable syringes, cartridges, vials, and ampoules.
  • Drug Delivery Systems: Pen injectors, auto-injectors, and wearable injectors.
  • Diagnostic Solutions: Laboratory consumables and regulatory support.
  • Machinery: Pharmaceutical visual inspection, assembling, packaging, and glass forming machines.
  • After-Sales Support: Spare parts and maintenance services.
  • Contract Manufacturing: Development and production of drug delivery devices.

Customer Base

The company serves a diverse range of clients, including:

  • Pharmaceutical and biotechnology firms.
  • Diagnostics and life sciences companies.
  • Contract manufacturers in drug product, glass packaging, and fill & finish operations.

Founded in 1949, Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L., continuing its legacy of innovation and excellence in the healthcare sector.

Frequently Asked Questions

As of 05/19/2025, Stevanato Group S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $6.49 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Stevanato Group S.p.A. global market capitalization ranking is approximately 2623 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Italy
Founded 1949
IPO Date 07/16/2021
Employees 5,521
CEO Franco Stevanato
Sector Healthcare
Industry Medical Instruments & Supplies
Address Via Molinella 17
Piombino Dese, PD 35017
Italy
Website https://www.stevanatogroup.com